Skip Nav Destination
Article navigation
letter|
August 23 2024
Some of the Non–Factor VIII Inhibitors Can Also Be Time-Dependent
Chaonan Liu, MD;
Chaonan Liu, MD
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Tao and Zhou contributed equally to this manuscript
Search for other works by this author on:
Liqin Ling, MD;
Liqin Ling, MD
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Tao and Zhou contributed equally to this manuscript
Search for other works by this author on:
Xunbei Huang, MD;
Xunbei Huang, MD
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Tao and Zhou contributed equally to this manuscript
Search for other works by this author on:
Juan Liao, MD;
Juan Liao, MD
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Tao and Zhou contributed equally to this manuscript
Search for other works by this author on:
Chuanmin Tao, MD, PhD;
Chuanmin Tao, MD, PhD
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Tao and Zhou contributed equally to this manuscript
Search for other works by this author on:
Jing Zhou, MD
Jing Zhou, MD
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Tao and Zhou contributed equally to this manuscript
Search for other works by this author on:
Arch Pathol Lab Med (2024)
Article history
Accepted:
June 25 2024
Citation
Chaonan Liu, Liqin Ling, Xunbei Huang, Juan Liao, Chuanmin Tao, Jing Zhou; Some of the Non–Factor VIII Inhibitors Can Also Be Time-Dependent. Arch Pathol Lab Med 2024; doi: https://doi.org/10.5858/arpa.2024-0219-LE
Download citation file:
Sponsored Video
42
Views
Citing articles via
High-Throughput Hybridization Assay as First-Line Diagnostic Test for Sarcomas: Clinical Assessment in a Tertiary Referral Center
Carmen Salguero-Aranda, PhD, Marco Perez, PhD, María Victoria Vargas-Padilla, Amparo Beltrán-Povea, PhD, Daniel Delgado-Bellido, PhD, David Marcilla, MD, Gema Civantos, MD, Enrique de Álava, MD, PhD, Juan Díaz-Martín, PhD
Evaluating Use of Generative Artificial Intelligence in Clinical Pathology Practice: Opportunities and the Way Forward
Peter McCaffrey, MD, MS, Ronald Jackups, MD, PhD, Jansen Seheult, MB, BCh BAO, MSc, MS, MD, Mark A. Zaydman, MD, PhD, Ulysses Balis, MD, Harshwardhan M. Thaker, MD, PhD, Hooman Rashidi, MD, MS, Rama R. Gullapalli, MD, PhD
Pediatric Myelodysplastic Syndrome: Updated Classifications and Current Diagnosis and Treatment Challenges
Zaina Inam, MD, Miao Pan, PhD, Yaser Diab, MD, Reuven Schore, MD, Anant Vatsayan, MD, Jinjun Cheng, MD, PhD
Preanalytical Phase Tumor Contaminants in Intraoperative Margins From Transoral Robotic Surgeries
Shilpa M. Rao, MD, Carissa M. Thomas, MD, PhD, Harishanker Jeyarajan, MD, Jason M. Warram, PhD, Benjamin J. Greene, MD, India E. Ellison, BS, BA, Susan D. McCammon, MD, PhD, Kirk P. Withrow, MD, Erin P. Buczek, MD, Logan D. Stone, BS, Diana Lin, MD, Rebecca Chernock, MD, Manuel Lora Gonzalez, MD
Machine Learning Assessment of Gestational Age in Accelerated Maturation, Delayed Maturation, Villous Edema, Chorangiosis, and Intrauterine Fetal Demise
Jeffery A. Goldstein, MD, PhD, Ramin Nateghi, PhD, Lee A. D. Cooper, PhD
Napsin-A Immunohistochemistry in the Diagnosis of Pulmonary Alveolar Proteinosis
Catherine Larose, MD, MSc, Charles Leduc, MD, Martin Chevrier, MD
A New Generation of Pathologists: Addressing Modern Curriculum and Educational Scholarship for Pathology Educators and Trainees After the End of the COVID-19 Pandemic
Casey P. Schukow, DO, Timothy Craig Allen, MD, JD
Harnessing the Power of Generative Artificial Intelligence in Pathology Education: Opportunities, Challenges, and Future Directions
Matthew J. Cecchini, MD, PhD, Michael J. Borowitz, MD, PhD, Eric F. Glassy, MD, Rama R. Gullapalli, MD, PhD, Steven N. Hart, PhD, Lewis A. Hassell, MD, Robert J. Homer, MD, PhD, Ronald Jackups, Jr, MD, PhD, Jeffrey L. McNeal, M.Ed, Scott R. Anderson, MD
Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non–Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies
Zhenhao Qi, PhD, Thomas Ha, BS, Wenqin Feng, PhD, Maha Karnoub, PhD, Kaline Pereira, MD, PhD, Ryota Shiga, BSc, Egbert F. Smit, MD, PhD, Yasushi Goto, MD, PhD, Adrianus Johannes De Langen, MD, Koichi Goto, MD, PhD, Anne Marie Velasco Roth, MS, Shirin Khambata-Ford, PhD
Ethical and Regulatory Perspectives on Generative Artificial Intelligence in Pathology
Brian R. Jackson, MD, MS, Hooman H. Rashidi, MD, MS, Jochen K. Lennerz, MD, PhD, M. E. de Baca, MD